Amanda Rush/LinkedIn
Dec 22, 2025, 22:34
Amanda Rush and Other Researchers Spoke with 87 Australians Affected by a Range of Blood Disorders
Haemophilia Foundation Australia shared a post on LinkedIn:
“Gene therapies are creating new hope for people with serious conditions like haemophilia. These treatments can be life-changing, but they also raise important questions: how should we pay for them, who should have access, and what happens when the long-term effects are still uncertain?
In the latest issue of National Haemophilia, Amanda Rush and other researchers spoke with 87 Australians affected by a range of blood disorders as part of a study led by the University of Sydney.
Thanks to the people and parents of children with haemophilia who participated in this research.
Read the results.”

Stay informed with latest blood disorders updates on Hemostasis Today.
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation